CN113662993A - Antiviral veterinary drug and preparation method thereof - Google Patents
Antiviral veterinary drug and preparation method thereof Download PDFInfo
- Publication number
- CN113662993A CN113662993A CN202111178971.1A CN202111178971A CN113662993A CN 113662993 A CN113662993 A CN 113662993A CN 202111178971 A CN202111178971 A CN 202111178971A CN 113662993 A CN113662993 A CN 113662993A
- Authority
- CN
- China
- Prior art keywords
- parts
- veterinary drug
- filtering
- antiviral
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000273 veterinary drug Substances 0.000 title claims abstract description 28
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 17
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 238000001914 filtration Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000009835 boiling Methods 0.000 claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000004347 Perilla Nutrition 0.000 claims abstract description 11
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 11
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 235000011477 liquorice Nutrition 0.000 claims abstract description 11
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 238000002791 soaking Methods 0.000 claims abstract description 5
- 239000012153 distilled water Substances 0.000 claims abstract description 4
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 238000001694 spray drying Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 244000124853 Perilla frutescens Species 0.000 claims abstract 3
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 3
- 241000045403 Astragalus propinquus Species 0.000 claims description 9
- 238000001125 extrusion Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 2
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 230000006806 disease prevention Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 210000004233 talus Anatomy 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 14
- 241000229722 Perilla <angiosperm> Species 0.000 description 8
- 241000245665 Taraxacum Species 0.000 description 8
- 229940079593 drug Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- -1 vaccines Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides an antiviral veterinary drug, which comprises the following raw materials of dandelion, astragalus, rhizoma atractylodis, liquorice, perilla leaf, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn; a preparation method of an antiviral veterinary drug comprises soaking raw materials for 1 hr, filtering, adding 15 times of water into the raw materials, boiling for 1 hr, separating to obtain a medicinal liquid A and a residue A, adding 15 times of water into the residue A, boiling for 1 hr, separating to obtain a medicinal liquid B and a residue B, filtering the medicinal liquid A and the medicinal liquid B with 80 mesh sieve, concentrating the medicinal liquid to relative density of 1.10 to obtain an extractive solution, adding yeast powder into the extractive solution, stirring, adding distilled water to obtain an extractive solution with relative density of 1.12, filtering with 80 mesh sieve, spray drying the filtrate to obtain powder, and dry-extruding and granulating to obtain granules; the traditional Chinese medicine composition is mainly prepared from cheap medicinal materials, is very low in cost, is convenient to popularize and use, achieves the functions of pre-disease prevention and post-disease conditioning, has no toxic or side effect, does not generate drug resistance, and does not cause harm to human bodies.
Description
Technical Field
The invention relates to the technical field of antiviral veterinary drugs, and particularly relates to an antiviral veterinary drug and a preparation method thereof.
Background
Veterinary Drugs (Veterinary Drugs): means a substance (drug-containing feed additive) for preventing, treating, diagnosing animal diseases or purposefully regulating animal physiological functions. The veterinary drug mainly comprises: serum products, vaccines, diagnostic products, microecological products, traditional Chinese medicinal materials, Chinese patent medicines, chemicals, antibiotics, biochemical medicines, radiopharmaceuticals, topical insecticides, disinfectants, etc.
At the farm of our country, when every spring warms up to bloom, the farm breeds a large amount, produce a large amount of heat, easily multiple infectious diseases, it is indispensable to strengthen the immunity and the antiviral ability of domestic animal, it disinfects to adopt chemical mostly now in the farm, this kind of method has reduced the production performance on the contrary, make the domestic animal produce drug resistance, influence meat, egg quality, do not have safe nontoxic at present, the antiviral traditional Chinese veterinary medicine material of effect demonstration promotion poultry, consequently, develop a traditional Chinese veterinary medicine material that is nontoxic to people and livestock, the promotion poultry antiviral ability of no side effect becomes the problem that needs the solution at present urgently.
Disclosure of Invention
In view of the problems in the prior art, the invention discloses an antiviral veterinary drug, which comprises the following raw materials in parts by weight: 15-25 parts of dandelion, 20-70 parts of astragalus membranaceus, 10-35 parts of rhizoma atractylodis, 15-25 parts of liquorice, 1-5 parts of perilla leaf, 5-10 parts of radix bupleuri, 20-40 parts of honeysuckle, 25-35 parts of platycodon grandiflorum, 4-6 parts of hawthorn and 1 part of yeast powder.
As a preferable technical scheme, the veterinary drug is in a granular form.
According to a preferable technical scheme of the invention, the yeast powder is natural yeast powder, and the natural yeast is added into the veterinary drug, so that dyspepsia caused by unreasonable diet can be treated, and the effect of regulating metabolism function to a certain degree can be achieved.
As a preferred technical scheme of the invention, the hawthorn is hawthorn slices, and the hawthorn can play roles in promoting digestion, resisting bacteria, strengthening heart and reducing blood fat, and has the effects of promoting digestion, invigorating stomach, promoting blood circulation and removing blood stasis.
A preparation method of an antiviral veterinary drug comprises the following steps:
step 1, soaking dandelion, astragalus membranaceus, rhizoma atractylodis, liquorice, perilla leaves, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn for 1-2 hours, and discharging residue soil and impurities of residues in the raw materials after soaking and filtering;
step 2, filtering the raw materials in the step 1, adding 15 times of water, boiling for 1 hour, separating a liquid medicine A and medicine residues A, and standing and storing the separated liquid medicine A;
step 3, adding 15 times of water into the medicine residue A obtained in the step 2, boiling for 1 hour, separating the medicine liquid B from the medicine residue B, and directly discarding the separated medicine residue B after boiling twice;
step 4, filtering the liquid medicine A and the liquid medicine B by using a 80-mesh sieve, and concentrating the liquid medicine until the relative density is 1.10 to obtain an extracting solution;
step 5, adding the extract obtained in the step 4 into yeast powder, uniformly stirring, and adding distilled water to finally obtain an extract with the relative density of 1.12;
and 6, filtering by using an 80-wood sieve, carrying out spray drying on the filtrate to obtain powder, and carrying out dry extrusion granulation to obtain granules.
The invention has the beneficial effects that: the hawthorn and the saccharomycetes can play roles in improving the gastrointestinal tract environment, inhibiting pathogenic bacteria, enhancing immunity and the like, realize the functions of pre-disease prevention and post-disease conditioning, have no toxic or side effect, do not generate drug resistance and do not cause harm to human bodies.
Detailed Description
Example 1
The invention discloses an antiviral veterinary drug, which comprises the following raw materials in parts by weight: 15 parts of dandelion, 20 parts of astragalus membranaceus, 10 parts of rhizoma atractylodis, 15 parts of liquorice, 1 part of perilla leaf, 5 parts of radix bupleuri, 20 parts of honeysuckle, 25 parts of platycodon grandiflorum, 4 parts of hawthorn and 1 part of yeast powder.
As a preferable technical scheme, the veterinary drug is in a granular form, and the granular veterinary drug is not easy to disintegrate and dissolve out, and the granules are quickly dissolved and released and are easy to absorb and utilize.
As a preferred technical scheme of the invention, the yeast powder is natural yeast powder.
As a preferred technical scheme of the invention, the hawthorn is hawthorn slices.
A preparation method of an antiviral veterinary drug comprises the following steps:
step 1, soaking dandelion, astragalus membranaceus, rhizoma atractylodis, liquorice, perilla leaves, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn for 1 hour; step 2, filtering the soaked raw materials by using a screen, placing the filtered water for no use, adding 15 times of water into the filtered raw materials, placing the filtered raw materials in a boiling pot, boiling for 1 hour, and separating liquid medicine A and dregs A in the boiling pot; step 3, separating the liquid medicine A in the step 2, standing, putting the decoction dregs A into the boiling pot again, adding 15 times of water, boiling for 1 hour, and separating the liquid medicine B and the decoction dregs B; step 4, filtering the liquid medicine A and the liquid medicine B by using a 80-mesh sieve, and concentrating the mixed liquid medicine of the liquid medicine A and the liquid medicine B until the relative density is 1.10 to obtain an extracting solution; step 5, adding the extract obtained in the step 4 into yeast powder, uniformly stirring, and adding distilled water to finally obtain an extract with the relative density of 1.12; and 6, filtering by using an 80-wood sieve, carrying out spray drying on the filtrate to obtain powder, and carrying out dry extrusion granulation to obtain granules.
Example 2
The difference between the embodiment and the embodiment 1 is that the antiviral veterinary drug comprises the following raw materials in parts by weight: 25 parts of dandelion, 70 parts of astragalus membranaceus, 35 parts of rhizoma atractylodis, 25 parts of liquorice, 5 parts of perilla leaf, 10 parts of radix bupleuri, 40 parts of honeysuckle, 35 parts of platycodon grandiflorum, 6 parts of hawthorn and 1 part of yeast powder.
In the preparation method of the antiviral veterinary drug, step 1, dandelion, astragalus membranaceus, rhizoma atractylodis, liquorice, perilla leaf, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn are soaked for 2 hours.
Example 3
The difference between the embodiment and the embodiment 1 is that the antiviral veterinary drug comprises the following raw materials in parts by weight: 20 parts of dandelion, 45 parts of astragalus, 22.5 parts of rhizoma atractylodis, 20 parts of liquorice, 3 parts of perilla leaf, 7.5 parts of radix bupleuri, 30 parts of honeysuckle, 30 parts of platycodon grandiflorum, 5 parts of hawthorn and 1 part of yeast powder.
In the preparation method of the antiviral veterinary drug, step 1, dandelion, astragalus membranaceus, rhizoma atractylodis, liquorice, perilla leaf, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn are soaked for 1.5 hours.
Although the present invention has been described in detail with reference to the specific embodiments, the present invention is not limited to the above embodiments, and various changes and modifications without inventive changes may be made within the knowledge of those skilled in the art without departing from the spirit of the present invention.
Claims (5)
1. An antiviral veterinary drug, which is characterized in that: the antiviral veterinary drug comprises the following raw materials in parts by weight: 15-25 parts of dandelion, 20-70 parts of astragalus membranaceus, 10-35 parts of rhizoma atractylodis, 15-25 parts of liquorice, 1-5 parts of perilla leaf, 5-10 parts of radix bupleuri, 20-40 parts of honeysuckle, 25-35 parts of platycodon grandiflorum, 4-6 parts of hawthorn and 1 part of yeast powder.
2. The antiviral veterinary drug according to claim 1, wherein: the veterinary drug is in a granular form.
3. The antiviral veterinary drug according to claim 1, wherein: the yeast powder is natural yeast powder.
4. The antiviral veterinary drug according to claim 1, wherein: the fructus crataegi is fructus crataegi slice.
5. A preparation method of an antiviral veterinary drug is characterized by comprising the following steps: the method comprises the following steps:
step 1, soaking dandelion, astragalus membranaceus, rhizoma atractylodis, liquorice, perilla leaves, radix bupleuri, honeysuckle, platycodon grandiflorum and hawthorn for 1-2 hours;
step 2, filtering the raw materials in the step 1, adding 15 times of water, boiling for 1 hour, and separating a liquid medicine A and a decoction dreg A;
step 3, adding 15 times of water into the medicine residue A obtained in the step 2, boiling for 1 hour, and separating medicine liquid B and medicine residue B;
step 4, filtering the liquid medicine A and the liquid medicine B by using a 80-mesh sieve, and concentrating the liquid medicine until the relative density is 1.10 to obtain an extracting solution;
step 5, adding the extract obtained in the step 4 into yeast powder, uniformly stirring, and adding distilled water to finally obtain an extract with the relative density of 1.12;
and 6, filtering by using an 80-wood sieve, carrying out spray drying on the filtrate to obtain powder, and carrying out dry extrusion granulation to obtain granules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111178971.1A CN113662993A (en) | 2021-10-11 | 2021-10-11 | Antiviral veterinary drug and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111178971.1A CN113662993A (en) | 2021-10-11 | 2021-10-11 | Antiviral veterinary drug and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113662993A true CN113662993A (en) | 2021-11-19 |
Family
ID=78550606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111178971.1A Pending CN113662993A (en) | 2021-10-11 | 2021-10-11 | Antiviral veterinary drug and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113662993A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658551A (en) * | 2008-08-27 | 2010-03-03 | 新乡博凯生物技术有限公司 | Honeysuckle composition for resisting virus diseases of pigs |
| CN106619949A (en) * | 2015-11-02 | 2017-05-10 | 重庆安尚园农业科技发展有限公司 | Veterinary drug with broad-spectrum bactericidal and antiviral effects |
-
2021
- 2021-10-11 CN CN202111178971.1A patent/CN113662993A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658551A (en) * | 2008-08-27 | 2010-03-03 | 新乡博凯生物技术有限公司 | Honeysuckle composition for resisting virus diseases of pigs |
| CN106619949A (en) * | 2015-11-02 | 2017-05-10 | 重庆安尚园农业科技发展有限公司 | Veterinary drug with broad-spectrum bactericidal and antiviral effects |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101468099B (en) | Chinese medicinal composition for dispersing wind, relieving exterior syndrome, clearing heat and detoxicating, and method for preparing the same | |
| CN101698024A (en) | Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof | |
| CN107183407A (en) | A kind of fresh-water fishes disease prevention Chinese herbal feed formula and its production technology | |
| CN101810716A (en) | Preparation method of Chinese pulsatilla root submicron powder at normal temperature | |
| CN106362020A (en) | Pine pollen composition with defaecation improving effect and preparation method of pine pollen | |
| CN104523945A (en) | Chinese veterinary medicine composition for treating yellow-white dysentery of piglets and preparation method and application thereof | |
| CN110507771A (en) | It is a kind of for preventing and treating the drug and preparation method thereof of animal digestion syndrome | |
| CN113662993A (en) | Antiviral veterinary drug and preparation method thereof | |
| CN102488755B (en) | Fishing Chinese herbal composition capable of inhibiting germs and preparation method thereof | |
| CN101524479B (en) | Medicine for curing avian infectious bronchitis | |
| CN104940404A (en) | Preparation for preventing pullorum disease and preparation method | |
| CN105724831A (en) | Grouper feed and preparation method thereof | |
| CN105327262A (en) | Traditional Chinese medicine formula for treating constipation of children and preparing method of traditional Chinese medicine | |
| CN106913611A (en) | It is a kind of for strengthening immune herbal medicine and preparation method thereof | |
| CN104840591A (en) | Traditional Chinese medicine composition with effect of preventing and treating Newcastle disease | |
| CN104758390A (en) | Botanical drug compound preparation for preventing and treating porcine diarrhea and preparation method thereof | |
| CN103610975A (en) | Preparation method of cattle medicine for promoting digestion | |
| CN102451265A (en) | Effervescent traditional Chinese medicine composition for treating livestock constipation and preparation method thereof | |
| CN108403866B (en) | Traditional Chinese medicine granule for preventing and treating avian influenza and improving chicken flock immunity and preparation method thereof | |
| CN105853532A (en) | Chinese herbal medicinal bait for preventing and treating Aeromonas hydrophila induced diseases of Chinese softshell turtles, and preparation method thereof | |
| CN101313925B (en) | Sanshi detoxication powder | |
| CN106266145A (en) | A kind of Chinese herbal and crude drugs preparations for preventing and treating plant modification green grass or young crops willow clam Common Diseases | |
| CN106265984A (en) | A kind of Chinese herbal and crude drugs preparations for preventing and treating pond culture Penaeus vannamei Common Diseases | |
| CN106173512A (en) | A kind of Chinese medicine feed additive treating avian dysentery and preparation method thereof | |
| CN103610969A (en) | Preparation method of mixable cattle medicine for promoting digestion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211119 |
|
| RJ01 | Rejection of invention patent application after publication |